- Report
- June 2023
- 184 Pages
Asia Pacific
From €3090EUR$3,450USD£2,634GBP
- Report
- March 2023
- 185 Pages
Global
From €3986EUR$4,450USD£3,398GBP
- Report
- July 2023
- 140 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- July 2023
- 140 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- May 2023
- 147 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- December 2023
- 206 Pages
Global
€4474EUR$4,995USD£3,814GBP
- Report
- May 2023
- 83 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- February 2024
- 83 Pages
Global
From €3500EUR$4,186USD£3,088GBP
Alpha emitters are a type of radioactive material used in nuclear medicine and radiopharmacology. They are used to diagnose and treat diseases such as cancer, and are typically administered to patients through intravenous injections. Alpha emitters are composed of short-lived, high-energy particles that can be used to target and destroy cancer cells. They are also used in research to study the effects of radiation on cells and tissues.
The alpha emitter market is a rapidly growing sector of the nuclear medicine and radiopharmacology industry. It is driven by the increasing demand for more effective treatments for cancer and other diseases. The market is expected to continue to grow as new technologies and treatments are developed.
Some of the major companies in the alpha emitter market include Nordion, Eckert & Ziegler, and IBA Molecular. These companies specialize in the production and distribution of alpha emitters for medical and research applications. Show Less Read more